OAMG
AUTL

Odey Asset Management Group’s Autolus Therapeutics AUTL Stock Holding History

Odey Asset Management Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$4.6M Hold
2,499,400
– – 1.21% 11
2022
Q4 		$4.75M Buy
+2,499,400
New +$6.32M 1.43% 10

Other funds holding AUTL

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Odey Asset Management Group's AUTL Position: Q1 2023 in Review

Odey Asset Management Group held its Autolus Therapeutics (AUTL) position steady in Q1 2023 at 2,499,400 shares worth $4.6M. The position accounts for 1.21% of the portfolio, ranked #11.

Odey Asset Management Group first reported a position in AUTL in Q4 2022 and has held it in 2 quarters since. The position peaked at $4.75M in Q4 2022. 65 funds tracked by Wall St. Rank hold AUTL as of Q1 2023.

  • Odey Asset Management Group held 2,499,400 shares of Autolus Therapeutics worth $4.6M as of Q1 2023.
  • Odey Asset Management Group left its Autolus Therapeutics share count unchanged in Q1 2023.
  • Autolus Therapeutics made up 1.21% of Odey Asset Management Group's portfolio in Q1 2023, its #11 holding.
  • Odey Asset Management Group first reported a position in Autolus Therapeutics in Q4 2022 and has held it in 2 quarters since.
  • Odey Asset Management Group's Autolus Therapeutics position peaked at $4.75M in Q4 2022.
  • 65 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2023.

Based on Odey Asset Management Group's 13F filing for Q1 2023, filed 15 May 2023.